Truist Financial Reaffirms Buy Rating for IQVIA (NYSE:IQV)
IQVIA (NYSE:IQV – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Truist Financial in a report issued on Monday,Benzinga reports. They presently have a $263.00 price target on the medical research company’s stock, up from their previous price target of $261.00. Truist Financial’s price target would indicate a potential upside […]
IQVIA (NYSE:IQV – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Truist Financial in a report issued on Monday,Benzinga reports. They presently have a $263.00 price target on the medical research company’s stock, up from their previous price target of $261.00. Truist Financial’s price target would indicate a potential upside […]
